Compare DNUT & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNUT | STAA |
|---|---|---|
| Founded | 1937 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Food Chains | Ophthalmic Goods |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 577.8M | 1.1B |
| IPO Year | 2021 | 1995 |
| Metric | DNUT | STAA |
|---|---|---|
| Price | $3.15 | $22.52 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 9 |
| Target Price | $4.15 | ★ $22.81 |
| AVG Volume (30 Days) | ★ 2.3M | 762.7K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $1,522,616,000.00 | $239,442,000.00 |
| Revenue This Year | $0.55 | $30.82 |
| Revenue Next Year | $3.59 | $8.41 |
| P/E Ratio | ★ N/A | $86.33 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.88 | $15.59 |
| 52 Week High | $5.11 | $35.87 |
| Indicator | DNUT | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 38.36 | 41.22 |
| Support Level | $3.09 | $21.72 |
| Resistance Level | $3.72 | $24.31 |
| Average True Range (ATR) | 0.13 | 0.94 |
| MACD | -0.04 | 0.04 |
| Stochastic Oscillator | 4.30 | 26.01 |
Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.